Conventional anti-dementia treatment group: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
6
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 4 1
Not applicable 1
Conditions being studied
| Condition | Trials |
|---|---|
| Alzheimer s Disease | 2 |
| Alzheimer Dementia (AD) | 1 |
| Alzheimer's Disease | 1 |
| Functional Magnetic Resonance Imaging | 1 |
| Lecanemab | 1 |
| MCI-AD, Early Stage Alzheimer's Disease | 1 |
Recruiting trials involving Conventional anti-dementia treatment group
- Evaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through Multi-omics Approachs
- The Clinical Study of Synaptic Plasticity-based Lencanumab for the Treatment of Early Alzheimer's Disease
Common questions
How many recruiting trials involve Conventional anti-dementia treatment group?
2 recruiting trials across 6 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.